Fresh analysis suggests that individuals who stop using new slimming jabs like semaglutide or tirzepatide may regain lost weight much more quickly than those who halt traditional lifestyle regimens.
Findings released in a prominent medical journal demonstrates that while overweight people can lose a large proportion of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying such treatments need to be cognizant of the danger of rapid rebound weight gain when the treatment is stopped," warns expert Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment mass in about one and a half years.
Analyzing Therapies
The study, which reviewed 37 of trials involving thousands of patients, contrasted the results of these new drugs with conventional dieting.
The team emphasize that individuals who lose weight through diet and exercise typically experience a more gradual creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Rebound
Experts suggest the way of the drugs accounts for the amplified regain.
These medications imitate a body's own chemical called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than normal may cause the system to produce less of its own natural hormone, and could lessen responsiveness to its actions," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication means appetite is uncontrolled, making excessive eating a significant risk."
An Ongoing Condition?
The NHS suggest the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, due to the significant potential of weight regain, the therapy might need to be long-term.
This view is reinforced by drug manufacturers, who state that the results "underscore the chronic character of excess weight," akin to managing conditions like high blood pressure.
Patient Testimonies
Users who have come off the medication report a intense return of hunger.
"It felt as if a switch activating and you're instantly ravenous," described an individual.
The struggle is worsened if individuals have not established sustainable lifestyle or habit modifications during treatment.
Growing Use
Recent estimates suggest that a significant number of adults in the UK have used these injections in the past year, with interest continuing to grow.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are effective agents for shedding pounds, they are not a permanent fix and lasting health benefits hinges on integrated behavioural management.
